With a strong clinical-phase pipeline, Agenus harnesses a combination of proprietary antibody platforms, including Retrocyte Show™ and SECANT®, and revolutionary mobile therapy methods, positioning alone for a vital contributor within the biotechnology and immunotherapy arena.Preserving independence and editorial freedom is essential to our miss